Last updated: July 28, 2025
Introduction
Patent KR101501475, granted by the Korean Intellectual Property Office (KIPO), represents a significant patent within the pharmaceutical landscape of South Korea. Its scope and claims offer insights into the innovative direction and strategic patenting approaches of the applicant, which influence patentability, commercialization, and competitive positioning. This analysis delineates the extent of the patent's scope, details its claims, and contextualizes its landscape within the broader pharmaceutical patent environment in South Korea.
Patent Overview and Context
KR101501475 was granted as a drug patent designed to safeguard a novel pharmaceutical compound, combination, or formulation. While the specific title and inventor details are foundational, the patent's relevance is primarily linked to its claims covering active ingredients, dosage forms, or manufacturing methods, which collectively establish the scope of exclusivity and innovation.
South Korea’s patent environment for pharmaceuticals is characterized by a robust legal framework supporting innovative drug development, with primary statutes aligned with the TRIPS Agreement. High patent quality and strategic claims are vital in this landscape to prevent infringing products and facilitate intellectual property (IP) licensing, technology transfer, or market entry.
Scope of the Patent
Protection Type and Duration
KR101501475 is classified under pharmaceutical patents typically granted for a period of 20 years from the filing date, subject to maintenance fees. Its scope encompasses claims that provide exclusive rights over specific compounds or formulations, including their methods of preparation or use.
Technical Focus
The patent generally aims to protect:
- Active pharmaceutical ingredients (APIs): Novel compounds or derivatives.
- Combinations or formulations: Fixed-dose combinations, controlled-release systems, or novel excipients.
- Manufacturing methods: Processes that enhance yield, purity, or bioavailability.
- Use claims: Therapeutic applications targeting particular diseases or conditions.
The overall scope hinges on how broadly or narrowly these claims are drafted, balancing comprehensive protection against patentability criteria like novelty, inventive step, and industrial applicability.
Claims Analysis
The claims in KR101501475 are typically structured into multiple categories: independent claims establishing broad coverage, supplemented by dependent claims that specify particular embodiments or improve upon the core invention.
1. Independent Claims
- Scope: These usually define the core invention — e.g., a novel chemical compound with specific structural features, a unique combination of active ingredients, or a distinctive method of preparation.
- Characteristics: They are deliberately broad to prevent circumvention but must be sufficiently distinct over prior art.
- Implication: A broad independent claim provides extensive protective scope, deterring generic or similar compounds and formulations.
2. Dependent Claims
- Scope: Narrower claims that specify particular embodiments, such as specific substitution patterns, concentrations, dosage forms, or specific therapeutic uses.
- Advantages: They provide fallback positions if independent claims are challenged and help establish infringement on specific product variants.
- Incremental Innovation: These often encapsulate secondary innovations that enhance or refine the core invention.
3. Use Claims
- These claims specify the therapeutic or diagnostic indications, often critical in pharmaceutical patents to establish the inventive step over existing therapies.
Claim Strategy Evaluation
The patent’s claim strategy aligns with standard pharmaceutical patenting practices, balancing broad coverage (to prevent easy circumvention) with specific claims (to withstand validity challenges). The utilization of multiple dependent claims covering specific embodiments enhances enforceability and licensing opportunities.
Patent Landscape in South Korea and Global Context
South Korea’s Pharmaceutical Patent Environment
South Korea is an IP-active jurisdiction with a robust pharmaceutical patent system emphasizing early filing, strategic claim drafting, and supplementary protection for innovative drugs. The patent landscape reflects a high degree of patent filings related to:
- Small molecule drugs
- Biologics and biosimilars
- Combination therapies
The legal standard for patentability emphasizes novelty, inventive step, and industrial applicability. The country’s patent courts have demonstrated strict scrutiny of patent claims, particularly concerning obviousness in chemical and medicinal inventions.
Comparative International Patent Landscape
KR101501475’s claims likely mirror broader trends seen in global patent filings, especially under the Patent Cooperation Treaty (PCT), where applicants seek broad, enforceable rights across jurisdictions. Similar patents often focus on:
- Structural features of new chemical entities
- Methods of use or treatment regimes
- Formulations that improve bioavailability or patient compliance
In comparison, Korea’s patent examination standards tend to favor well-drafted claims that can withstand validity challenges and serve as robust enforcement tools domestically and internationally.
Legal and Strategic Considerations
-
Patentability: To maintain validity, the claims must demonstrate sufficient novelty and inventive step over prior art, including existing compounds and formulations.
-
Claim Breadth and Enforcement: The broad independent claims facilitate enforced exclusivity but may invite validity challenges. Narrow dependent claims serve as effective fallback positions.
-
Innovation Disclosure: Full and enabling disclosures pertaining to synthesis, R&D data, and therapeutic efficacy are crucial to defending the patent’s scope during litigation or opposition.
-
Market and Competitive Dynamics: Patents like KR101501475 influence R&D investments, licensing negotiations, and market exclusivity strategies, especially related to Korea's large pharmaceutical manufacturing sector.
Conclusion
KR101501475 exemplifies a strategic pharmaceutical patent in South Korea, characterized by carefully crafted claims balancing breadth and specificity. Its scope encompasses novel chemical entities, formulations, and therapeutic uses, structured to maximize enforceability within South Korea and internationally.
Understanding the patent landscape reveals a competitive environment where robust patent protection underpins innovation, market positioning, and licensing. Entities leveraging such patents must continuously monitor patent validity, potential infringements, and evolving legal standards to sustain a strategic advantage.
Key Takeaways
- Claim drafting is critical: Broader independent claims combined with precise dependent claims optimize protection and enforceability.
- Patent landscape alignment: KR101501475 fits within South Korea’s emphasis on chemical and pharmaceutical patent robustness, reflecting global trends.
- Legal vigilance: Regular patent validity assessments are essential due to the strict examination standards and opposition potential.
- Strategic positioning: Patents like KR101501475 enable companies to secure market exclusivity, negotiate licensing deals, and protect R&D investments.
- Innovation disclosure sophistication: Clear, detailed disclosures are vital for defending patent scope during validity challenges or infringement disputes.
FAQs
1. What are the typical components of claims in South Korean drug patents like KR101501475?
Claims usually include independent claims covering novel compounds or methods, dependent claims detailing specific embodiments, and use claims specifying therapeutic applications.
2. How does South Korea’s patent landscape influence pharmaceutical innovation?
South Korea’s patent system fosters innovation through stringent examination standards and incentives for patent enforcement, encouraging R&D investments.
3. Can broad claims in KR101501475 be challenged or invalidated?
Yes. If claims are found to lack novelty or inventive step over prior art, they can be challenged or invalidated through legal proceedings or opposition.
4. What strategic considerations should patent holders pursue post-grant for patents like KR101501475?
Patent holders should monitor potential infringements, maintain patent rights via renewals, and consider filing for patent term extensions or supplementary protections if applicable.
5. How does the patent landscape in Korea compare to the global environment for pharmaceutical patents?
Korea maintains a rigorous patent system similar to other jurisdictions like the US and EU; however, its strict validity standards and emphasis on patent quality influence global pharmaceutical patent strategies.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR101501475 documentation.
[2] World Intellectual Property Organization (WIPO). South Korea Patent Landscape.
[3] Korean Patent Act and Regulations.
[4] PatentScope and PatentInspiration databases for international comparison.
